Literature DB >> 1326232

Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.

B A Gingras1, J B Jensen.   

Abstract

Several antibiotics, including the macrolide erythromycin and the azalides azithromycin (CP-62,993) and CP-63,956, that inhibit protein synthesis on 70S ribosomes demonstrated antimalarial effects in vitro against two strains of Plasmodium falciparum, one sensitive to chloroquine and the other resistant. In 48-hr incubations, erythromycin was 10-fold less potent than the azalides against the chloroquine-resistant strain. Erythromycin and the azalides were essentially equipotent against the chloroquine-sensitive strain. An additive effect occurred with the azalides in combination with chloroquine against both strains, but this was not seen with erythromycin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326232     DOI: 10.4269/ajtmh.1992.47.378

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.

Authors:  B Pradines; C Rogier; T Fusai; J Mosnier; W Daries; E Barret; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine.

Authors:  Marcus R Pereira; Philipp P Henrich; Amar Bir Singh Sidhu; David Johnson; Joel Hardink; Jeffrey Van Deusen; Jian Lin; Katrina Gore; Connor O'Brien; Mamadou Wele; Abdoulaye Djimde; Richa Chandra; David A Fidock
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

3.  Evaluation of the Combination of Azithromycin and Naphthoquine in Animal Malaria Models.

Authors:  Zhu-Chun Bei; Guo-Fu Li; Jing-Hua Zhao; Min Zhang; Xiao-Guang Ji; Jing-Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

4.  Treatment and control of mycoplasma contamination in Plasmodium falciparum culture.

Authors:  Shubhra Singh; S K Puri; Kumkum Srivastava
Journal:  Parasitol Res       Date:  2008-09-30       Impact factor: 2.289

5.  Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.

Authors:  Danny W Wilson; Christopher D Goodman; Brad E Sleebs; Greta E Weiss; Nienke Wm de Jong; Fiona Angrisano; Christine Langer; Jake Baum; Brendan S Crabb; Paul R Gilson; Geoffrey I McFadden; James G Beeson
Journal:  BMC Biol       Date:  2015-07-18       Impact factor: 7.431

6.  Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria.

Authors:  Tiphaine Gaillard; Jérôme Dormoi; Marylin Madamet; Bruno Pradines
Journal:  Malar J       Date:  2016-02-12       Impact factor: 2.979

Review 7.  Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.

Authors:  R Matthew Chico; Rudiger Pittrof; Brian Greenwood; Daniel Chandramohan
Journal:  Malar J       Date:  2008-12-16       Impact factor: 2.979

Review 8.  Re-Envisioning Anti-Apicomplexan Parasite Drug Discovery Approaches.

Authors:  Gabriel W Rangel; Manuel Llinás
Journal:  Front Cell Infect Microbiol       Date:  2021-06-11       Impact factor: 5.293

Review 9.  Repurposing Drugs to Fight Hepatic Malaria Parasites.

Authors:  Diana Fontinha; Isabel Moules; Miguel Prudêncio
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

10.  Treatment of adults with acute uncomplicated malaria with azithromycin and chloroquine in India, Colombia, and Suriname.

Authors:  Nilima A Kshirsagar; Nithya J Gogtay; Diego Moran; Gregory Utz; Ashok Sethia; Shirsendu Sarkar; Pol Vandenbroucke
Journal:  Res Rep Trop Med       Date:  2017-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.